Antibodies against phosphorylcholine in combination therapy with biologic agents
AssigneeAthera Biotechnologies AB
InventorJohan FROSTEGÅRD
Life of this patent
Estimating the term…
Loading patent…
AssigneeAthera Biotechnologies AB
InventorJohan FROSTEGÅRD
Estimating the term…
Antibodies against PC, PC conjugate or bioactive components and/or fragments thereof for use in combination therapy with one or more biologic agents and/or stem cells are disclosed, as well as compositions comprising the antibodies in combination with one or more biologic agents and/or stem cells. Also disclosed are PC conjugates, PC or bioactive components and/or parts/fragments thereof for use in activation immunotherapy prior to or in combination with treatment with biologic agents and/or stem cells for curing, treating, preventing, and/or reducing the risk of developing auto-immune diseases, chronic inflammatory diseases, and cancer diseases, as well as compositions comprising them in combination with biologic agents and/or stem cells.
A method for increasing the efficacy of a biological agent for curing, treating, preventing, and/or reducing the risk of developing rheumatoid arthritis, said method comprising:
Dependencies are inferred from the claim text.